VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MXL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MXLMaxLinear, Inc.
$49.18$4.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMXLFinancials

MaxLinear, Inc. (MXL) Income Statement

19Y historyFree accessUpdated daily

Revenue growth has swung from a -50.0% contraction in 2024Q2 to +72.4% expansion in 2026Q3 on $218.1M of revenue, lifting gross margin 510bps to 58.7% and producing a first materially positive operating quarter of $30.2M (13.9% operating margin) and $0.30 diluted EPS after seven consecutive loss-making periods.

Income StatementBalance SheetCash FlowRatios

MXL Income Statement

Annual statement

MXL Income Statement

MaxLinear, Inc. (MXL) annual income statement — 19-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07
Sales/Revenue660.53M467.64M360.53M693.26M1.12B892.4M478.6M317.18M385M420.32M387.83M300.36M133.11M119.65M97.73M71.94M68.7M51.35M31.33M9.7M
Revenue Growth %56.02%29.71%-48%-38.12%25.53%86.46%50.89%-17.61%-8.4%8.38%29.12%125.64%11.25%22.43%35.85%4.71%33.79%63.9%223.13%-
Cost of Goods Sold277.35M201.83M168.11M310.48M482.44M420.19M289.33M172.58M208.35M241.73M157.84M144.94M51.15M45.58M37.02M26.62M21.56M17.05M12.68M4.9M
COGS % of Revenue-43.16%46.63%44.79%43.07%47.09%60.45%54.41%54.12%57.51%40.7%48.25%38.43%38.1%37.88%37%31.38%33.2%40.46%50.5%
Gross Profit383.17M265.81M192.42M382.78M637.81M472.2M189.26M144.6M176.65M178.59M229.99M155.42M81.96M74.06M60.71M45.32M47.14M34.3M18.66M4.8M
Gross Margin %58.01%56.84%53.37%55.21%56.93%52.91%39.55%45.59%45.88%42.49%59.3%51.75%61.57%61.9%62.12%63%68.62%66.8%59.54%49.5%
Gross Profit Growth %-38.15%-49.73%-39.99%35.07%149.49%30.89%-18.14%-1.08%-22.35%47.98%89.64%10.66%22%33.95%-3.86%37.43%83.87%288.67%-
Operating Expenses388.76M392.7M361.15M398.78M452.49M404.75M272.24M164.02M189.71M178.73M156.48M157.76M90.52M84.06M73.62M60.33M43.64M29.71M20.67M14.22M
OpEx % of Revenue-83.98%100.17%57.52%40.39%45.36%56.88%51.71%49.28%42.52%40.35%52.52%68%70.26%75.33%83.87%63.52%57.86%65.96%146.66%
Selling, General & Admin167.11M159.58M135.96M129.28M156.05M126.32M92.25M65.73M69.81M67M58.73M72.35M33.89M30.93M27.23M20.18M15.91M9.92M6.36M4.3M
SG&A % of Revenue-34.12%37.71%18.65%13.93%14.15%19.28%20.72%18.13%15.94%15.14%24.09%25.46%25.85%27.86%28.05%23.16%19.32%20.29%44.31%
Research & Development221.53M208.6M225.19M269.5M296.44M278.44M179.99M98.3M119.9M111.73M97.75M85.41M56.63M53.13M46.39M40.16M27.73M19.79M14.31M9.92M
R&D % of Revenue-44.61%62.46%38.87%26.46%31.2%37.61%30.99%31.14%26.58%25.2%28.43%42.54%44.41%47.47%55.82%40.36%38.54%45.67%102.35%
Other Operating Expenses120K24.52M000000000000000000
Operating Income-5.58M-126.89M-168.74M-16M185.32M67.45M-82.98M-19.42M-13.06M-147K73.51M-2.33M-8.56M-10M-12.91M-15.01M3.5M4.59M-2.01M-9.42M
Operating Margin %-0.85%-27.13%-46.8%-2.31%16.54%7.56%-17.34%-6.12%-3.39%-0.03%18.95%-0.78%-6.43%-8.36%-13.21%-20.87%5.1%8.94%-6.42%-97.15%
Operating Income Growth %-24.8%-954.8%-108.63%174.75%181.29%-327.25%-48.69%-8785.03%-100.2%3250.92%72.74%14.42%22.53%14.02%-528.45%-23.69%328.46%78.66%-
EBITDA30.38M-82.9M-122.58M46.64M257.22M151.86M-10.36M44.89M65.97M66.59M100.21M38.31M-3.45M-6.29M-9.38M-11.85M5.38M5.43M-1.4M-8.95M
EBITDA Margin %4.6%-17.73%-34%6.73%22.96%17.02%-2.16%14.15%17.13%15.84%25.84%12.75%-2.59%-5.25%-9.59%-16.48%7.83%10.58%-4.48%-92.34%
EBITDA Growth %135.28%32.38%-362.84%-81.87%69.38%1565.93%-123.07%-31.94%-0.94%-33.55%161.6%1210.06%45.09%32.97%20.9%-320.46%-1.03%486.97%84.32%-
D&A (Non-Cash Add-back)35.97M43.99M46.15M62.63M71.9M84.41M72.62M64.31M79.03M66.74M26.7M40.64M5.11M3.71M3.53M3.16M1.87M841K606K467K
EBIT-4.62M-102.36M-227.84M-53.11M183.97M60.87M-101.9M-21.35M-18.6M-23.62M63.79M-42.81M-8.86M-12.35M-12.86M-14.96M3.77M4.61M-1.84M-8.63M
Net Interest Income-7.14M-6.67M-4.49M-4.65M-9.52M-12.92M-12.54M-10.36M-14.18M-10.1M468K175K221K218K229K223K297K-1K105K576K
Interest Income2.41M3.38M6.39M6.05M245K78K409K775K78K274K572K275K236K222K282K292K326K51K179K654K
Interest Expense9.55M10.06M10.87M10.7M9.77M13M12.95M11.13M14.26M10.38M104K100K15K4K53K69K29K52K74K78K
Other Income/Expense-9.25M-14M-69.98M-47.81M-11.12M-19.58M-31.88M-13.06M-19.79M-33.85M-9.82M-40.57M-187K-2.33M-3K-18K239K-33K96K711K
Pretax Income-14.84M-140.89M-238.72M-63.81M174.2M47.87M-114.85M-32.48M-32.85M-34M63.69M-42.91M-8.74M-12.33M-12.91M-15.03M3.74M4.56M-1.91M-8.71M
Pretax Margin %-2.25%-30.13%-66.21%-9.2%15.55%5.36%-24%-10.24%-8.53%-8.09%16.42%-14.28%-6.57%-10.31%-13.21%-20.89%5.45%8.88%-6.11%-89.82%
Income Tax14.54M-4.21M6.48M9.34M49.16M5.9M-16.26M-12.59M-6.65M-24.81M2.4M-575K-1.7M402K341K6.99M-6.37M230K078K
Effective Tax Rate %-97.99%2.99%-2.71%-14.63%28.22%12.33%14.16%38.75%20.25%72.98%3.77%1.34%19.49%-3.26%-2.64%-46.52%-170.21%5.04%0%-0.9%
Net Income-29.37M-136.68M-245.2M-73.15M125.04M41.97M-98.59M-19.9M-26.2M-9.19M61.29M-42.33M-7.04M-12.73M-13.25M-22.02M10.11M4.33M-1.91M-8.71M
Net Margin %-4.45%-29.23%-68.01%-10.55%11.16%4.7%-20.6%-6.27%-6.8%-2.19%15.8%-14.09%-5.29%-10.64%-13.56%-30.62%14.72%8.43%-6.11%-89.82%
Net Income Growth %83.65%44.26%-235.21%-158.5%197.93%142.57%-395.49%24.05%-185.17%-114.99%244.79%-501.21%44.7%3.92%39.83%-317.76%133.63%326.18%78.02%-
Net Income (Continuing)-29.37M-136.68M-245.2M-73.15M125.04M41.97M-98.59M-19.9M-26.2M-9.19M61.29M-42.33M-7.04M-12.73M-13.25M-22.02M10.11M4.33M-1.91M-8.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.30-1.58-2.93-0.911.550.53-1.35-0.28-0.38-0.140.91-0.79-0.19-0.37-0.40-0.680.300.06-0.19-0.76
EPS Growth %82.3%46.08%-221.98%-158.71%192.45%139.26%-382.14%26.32%-171.43%-115.38%215.19%-315.79%48.65%7.5%41.18%-326.67%400%131.58%75%-
EPS (Basic)--1.58-2.93-0.911.600.55-1.35-0.28-0.38-0.140.96-0.79-0.19-0.37-0.40-0.680.330.06-0.19-0.86
Diluted Shares Outstanding97.71M86.59M83.6M80.72M80.85M79.68M73.13M71M68.49M66.25M67.65M53.38M36.47M34.01M33.2M32.57M29.48M11.51M10.2M11.51M
Basic Shares Outstanding90.82M86.59M83.6M80.72M78.04M76.04M73.13M71M68.49M66.25M63.78M53.38M36.47M34.01M33.13M32.57M26.74M10.13M9.91M10.13M
Dividend Payout Ratio--------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Broadband cycle reversal risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Reverses Into Acceleration

MaxLinear's revenue growth has swung from a 50.0% contraction in 2024Q2 to 72.4% expansion in 2026Q3, with quarterly revenue climbing to $218.1M; as reported in the company's income statements, this sustained eight-quarter acceleration suggests a genuine demand inflection rather than merely an easy comparable.

The sequential path from $92.2M in 2024Q4 to $218.1M in 2026Q3 is unbroken, which argues against a one-quarter shipment pull-forward and points instead to a broadening order book across Broadband and Infrastructure. Because revenue is transactional rather than recurring, however, the durability of a 72.4% growth rate should be tested against whether it reflects inventory replenishment at distributors or true end-market consumption.

Mix Lift Pushes Gross Margin Higher

MaxLinear's gross margin has expanded 510 basis points from 53.6% in 2024Q3 to 58.7% in 2026Q3, modestly ahead of Silicon Laboratories at 58.2% and MACOM at 54.9%; based on the peer comparison, this gain implies improving product mix rather than broad pricing power.

The steady, monotonic margin climb alongside falling unit costs suggests the shift toward higher-content optical and Infrastructure silicon is contributing, which is structurally more favorable than cyclical price recovery. Still, at 58.7% the company remains below top-tier analog peers, so investors should treat the expansion as mix-driven and reversible if lower-margin Broadband volume regains share of the revenue mix.

Fixed R&D Base Drives Operating Leverage

Operating margin has swung from -47.7% in 2024Q3 to +13.9% in 2026Q3, with operating income recovering to $30.2M even as R&D held near $60.6M; per MaxLinear's income statement, this spread implies real operating leverage as revenue nearly tripled against a largely fixed engineering base.

R&D has fluctuated only between $47.2M and $65.5M across the ten quarters while revenue more than doubled, indicating that the cost structure is now absorbing growth rather than being consumed by it. The leverage cuts both ways, though: a comparable revenue contraction would push margins back toward breakeven quickly, so the fixed-cost intensity that flatters the recovery equally amplifies a downturn.

Equity Compensation Clouds Per-Share Quality

MaxLinear reported $28.9M of net income in 2026Q3 against $30.2M of operating income, yet stock-based compensation of $19.8M equaled roughly two-thirds of that operating profit; as disclosed in recent quarterly filings, this equity-funded pay mix and the anomalous 2026Q1 net loss warrant scrutiny of reported EPS quality.

The 2026Q1 net loss of $45.1M against an operating loss of only $16.7M implies material non-operating charges that are not explained by the core business, and similar gaps appear in 2024Q3 and 2025Q3, making period-to-period net income comparisons unreliable without further detail. Additionally, quarterly SBC has been lumpy, recorded at $0 in several quarters and $27.5M in 2026Q2, which suggests uneven recognition patterns that investors should normalize before extrapolating the $0.30 diluted EPS run-rate.

First Positive Operating Quarter Reached

The clearest inflection arrives in 2026Q3, when MaxLinear posted $30.2M of operating income and $0.30 diluted EPS, the first materially positive results in the ten-quarter series, on $218.1M of revenue; according to the company's reported results, this followed seven consecutive loss-making quarters and marks a decisive shift in earnings power.

What makes this inflection notable is that it was achieved without a visible reduction in R&D, meaning the turnaround came from the revenue line rather than cost engineering, which is generally the higher-quality path to profitability. The lasting implication is that the loss-making trough of 2024 may represent a cyclical floor rather than the steady state, though one profitable quarter is insufficient to establish a new margin baseline.

Margin Conversion Still Lags Revenue

MaxLinear's $60.6M R&D and $36.9M SG&A load leaves limited cushion beneath a 13.9% operating margin, and 2026Q2 EPS of $0.02 missed consensus despite 55.2% revenue growth; analysts observe this suggests profit conversion may lag the top-line recovery, exposing earnings to any demand wobble.

The strongest bear case is that the reported growth flatters a depressed base, since revenue was still contracting 50.0% as recently as 2024Q2, and that the 58.7% gross margin could compress if channel inventory clearing resumes in Connectivity and Broadband. Combined with heavy equity compensation and unexplained non-operating swings in quarterly net income, the risk is that the market extrapolates a 13.9% operating margin that the current cost structure cannot sustain through the next semiconductor down-cycle.

MXL — Frequently Asked Questions

Quick answers to the most common questions about buying MXL stock.

What was MaxLinear, Inc.'s (MXL) revenue in 2025?

For fiscal year 2025, MaxLinear, Inc. (MXL) reported total revenue of $467.6M. This represents a 4723.0% increase compared to $9.7M in 2007.

Is MaxLinear, Inc. (MXL) profitable?

MaxLinear, Inc. (MXL) reported a net loss of $136.7M for the fiscal year ending 2025.

What is MaxLinear, Inc.'s operating profit margin?

MaxLinear, Inc. (MXL) reported an operating income of $-126.9M, resulting in an operating profit margin of -27.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is MaxLinear, Inc.'s gross profit and gross margin?

MaxLinear, Inc. (MXL) generated $265.8M in gross profit for the year, representing a gross profit margin of 56.8%. This demonstrates the company's core pricing power and production efficiency.